Phibro Animal Health Corporation
$ 31.53
0.86%
12 Jun - close price
- Market Cap 1,279,006,000 USD
- Current Price $ 31.53
- High / Low $ 32.19 / 31.21
- Stock P/E 13.53
- Book Value 8.92
- EPS 2.33
- Next Earning Report 2026-08-26
- Dividend Per Share $0.48
- Dividend Yield 1.54 %
- Next Dividend Date 2026-06-24
- ROA 0.08 %
- ROE 0.30 %
- 52 Week High 59.83
- 52 Week Low 23.28
About
Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily in the United States. The company is headquartered in Teaneck, New Jersey.
Analyst Target Price
$45.60
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-06 | 2026-02-04 | 2025-11-05 | 2025-08-27 | 2025-05-07 | 2025-02-05 | 2024-11-07 | 2024-08-28 | 2024-05-08 | 2024-02-07 | 2023-11-08 | 2023-08-30 |
| Reported EPS | 0.76 | 0.87 | 0.73 | 0.57 | 0.63 | 0.54 | 0.17 | 0.41 | 0.31 | 0.33 | 0.14 | 0.38 |
| Estimated EPS | 0.71 | 0.67 | 0.6 | 0.52 | 0.52 | 0.45 | -0.04 | 0.33 | 0.29 | 0.28 | 0.23 | 0.38 |
| Surprise | 0.05 | 0.2 | 0.13 | 0.05 | 0.11 | 0.09 | 0.21 | 0.08 | 0.02 | 0.05 | -0.09 | 0 |
| Surprise Percentage | 7.0423% | 29.8507% | 21.6667% | 9.6154% | 21.1538% | 20% | 525% | 24.2424% | 6.8966% | 17.8571% | -39.1304% | 0% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-26 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.73 |
| Currency | USD |
Previous Dividend Records
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-06-24 | 2026-03-25 | 2025-12-17 | 2025-09-24 | 2025-06-25 | 2025-03-26 | 2024-12-18 | 2024-09-25 | 2024-06-26 | 2024-03-27 |
| Amount | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 |
Next Dividend Records
| Dividend per share (year): | $0.48 |
| Dividend Yield | 1.54% |
| Next Dividend Date | 2026-06-24 |
| Ex-Dividend Date | 2026-06-03 |
Recent News: PAHC
2026-06-03 15:07:00
Phibro Animal Health Corp shares rose over 10% following a director's purchase of Class A shares on the open market after a recent decline, despite ongoing investor concerns about Brazil's regulatory environment and the company's guidance. The company announced a quarterly cash dividend of 12 cents per share, and its latest quarterly net sales and adjusted EBITDA saw significant increases. However, recent analyst ratings have been cautious, with a consensus put at "Hold."
2026-06-03 05:09:34
Phibro Animal Health Corp. director E. Thomas Corcoran purchased 10,000 shares of the company's Class A Common Stock for $317,700 on May 29, 2026, at a weighted average price of $31.77 per share. This transaction increased his direct holdings to 41,459 shares. The purchase occurred shortly after the company announced strong Q3 fiscal year 2026 results, exceeding analyst expectations for both EPS and revenue, despite a subsequent dip in the stock price.
2026-06-03 02:09:56
E. Thomas Corcoran, a director at Phibro Animal Health Corp. (NASDAQ:PAHC), recently purchased 10,000 shares of the company's Class A Common Stock for a total of $317,700. This transaction occurred on May 29, 2026, at an average price of $31.77 per share. Following this purchase, Corcoran now directly holds 41,459 shares, and the acquisition comes as the stock trades at $28.52, down 15% over the past week, following a negative market reaction to strong Q3 fiscal year 2026 financial results that exceeded analyst forecasts.
2026-06-02 23:09:56
E. Thomas Corcoran, a director at Phibro Animal Health (PAHC), purchased 10,000 shares of Class A Common Stock in an open-market transaction. The shares were bought at a weighted average price of $31.77 per share. Following this acquisition, Corcoran directly holds 41,459 shares, which includes shares obtained through a dividend reinvestment plan.
2026-05-22 20:42:34
BFI Co., LLC and Jack C. Bendheim, major holders in Phibro Animal Health (PAHC), have filed an amended Schedule 13D disclosing a new Rule 10b5-1 sales plan. This plan authorizes Goldman Sachs to sell up to 750,000 shares of Class A Common Stock by March 17, 2027, with the first trading date on September 16, 2026. BFI currently beneficially owns 48.2% of PAHC's Class A Common Stock on an as-converted basis, and would still retain a substantial stake even if all shares under the plan are sold.
2026-05-21 20:41:37
Phibro Animal Health Corporation (Nasdaq: PAHC) announced its participation in the Stifel Jaws & Paws Conference. Key executives, including Daniel Bendheim, Larry Miller, and Glenn David, will address financial analysts and investors on May 27, 2026, at 9:45 AM ET in New York. A live audio presentation and replay will be available on the company's Investor Relations website.
